Organism name | Nicotiana tabacum |
---|---|
Genus | Nicotiana |
Family | Solanaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Nicotiana tabacum |
---|---|
Linked NCBI taxonomy ID | 4097 |
Linked level | species |
Family in NCBI taxonomy | Solanaceae |
---|---|
ID | 4070 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00006639
![]() |
Pelargonidin 3-rutinoside
|
No. 1 | No. 15 |
![]() |
||||
C00005472
![]() |
Quercetin 3-rutinoside-7-glucoside
|
No. 5 | No. 15 |
![]() |
||||
C00000001
![]() |
GA1
/ Gibberellin A1 |
C422660
|
No. 40 | No. 41 |
![]() |
|||
C00000020
![]() |
GA20
/ Gibberellin A20 |
No. 40 | No. 41 |
![]() |
||||
C00000009
![]() |
GA9
/ Gibberellin A9 |
No. 40 | No. 41 |
![]() |
||||
C00022371
![]() |
12alpha-Hydroxy-13-epimanoyl oxide
|
No. 70 |
![]() |
|||||
C00022724
![]() |
(8alpha,11E,13S)-11,14-Labdadiene-8,13-diol
|
No. 118 | No. 46 |
![]() |
||||
C00000875
![]() |
cis-Abienol
|
CHEMBL603753
|
No. 118 | No. 46 |
![]() |
|||
C00000894
![]() |
Sclareol
|
CHEMBL294740
CHEMBL464176 CHEMBL1369540 |
C070760
|
14 / 19 / 18 | No. 118 | No. 46 |
![]() |
|
C00022723
![]() |
(8alpha,11E,13R)-11,14-Labdadiene-8,13-diol
|
No. 118 | No. 46 |
![]() |
||||
C00007635
![]() |
5-epi-Aristolochene
|
CHEMBL484228
|
No. 151 | No. 38 |
![]() |
|||
C00000019
![]() |
GA19
/ Gibberellin A19 |
C120175
|
No. 187 | No. 41 |
![]() |
|||
C00002724
![]() |
Heriguard
/ Chlorogenic acid / 3-O-Caffeoylquinic acid |
CHEMBL284616
CHEMBL230481 CHEMBL249450 CHEMBL1332980 CHEMBL1394423 CHEMBL1419611 CHEMBL1473644 CHEMBL1552319 |
D002726
|
30 / 19 / 22 | 37 / 9 | No. 314 | No. 6 |
![]() |
C00002500
![]() |
Scopolin
|
CHEMBL225024
|
C417572
|
7 / 3 / 4 | No. 491 | No. 25 |
![]() |
|
C00003191
![]() |
Solavetivone
|
CHEMBL465907
|
No. 543 | No. 38 |
![]() |
|||
C00003125
![]() |
Debneyol
|
No. 613 | No. 38 |
![]() |
||||
C00022075
![]() |
Neophytadiene
|
No. 641 | No. 38 |
![]() |
||||
C00001434
![]() |
Tryptamine
/ beta-(3-Indolyl)ethylamine |
CHEMBL6640
|
C030820
|
20 / 5 / 7 | 6 / 2 | No. 710 | No. 4 |
![]() |
C00010291
![]() |
(2E,6S)-Dimethyl-2,7-octadiene-1,6-diol
|
No. 958 | No. 34 |
![]() |
||||
C00000095
![]() |
9-Ribosyl-cis-zeatin
/ 6-(4-Hydroxy-3-methyl-cis-2-butenylamino)-9-beta-D-ribofuranosylpurine |
No. 989 |
![]() |
|||||
C00000096
![]() |
9-Ribosyl-trans-zeatin
/ Zeatin-9-beta-D-ribofuranoside |
No. 989 |
![]() |
|||||
C00002686
![]() |
Acetosyringone
|
CHEMBL224146
|
C051667
|
3 / 11 / 10 | No. 1180 |
![]() |
||
C00001497
![]() |
3' 5'-cyclic AMP
|
CHEMBL9871
CHEMBL316966 CHEMBL1365681 CHEMBL1416083 CHEMBL1741513 CHEMBL2359042 |
D000242
|
29 / 24 / 19 | 80 / 7 | No. 1201 |
![]() |
|
C00000100
![]() |
IAA
/ Indole-3-acetic acid |
CHEMBL82411
|
C030737
|
3 / 0 / 0 | 2 / 1 | No. 1432 | No. 4 |
![]() |
C00000116
![]() |
IBA
/ Indole-3-butyric acid / 1H-Indole-3-butanoic acid |
CHEMBL582878
|
C014612
|
6 / 9 / 8 | No. 1432 | No. 4 |
![]() |
|
C00003108
![]() |
Capsidiol
|
C081843
|
No. 1914 | No. 38 |
![]() |
|||
C00002061
![]() |
(+)-Nornicotine
|
CHEMBL6200
CHEMBL264213 CHEMBL1132 |
4 / 2 / 1 | No. 2084 | No. 1 |
![]() |
||
C00002057
![]() |
Nicotine
|
CHEMBL3
CHEMBL9732 CHEMBL440464 CHEMBL1628647 |
D009538
|
131 / 72 / 55 | 370 / 191 | No. 2084 | No. 1 |
![]() |
C00002017
![]() |
Anatabine
|
C012737
|
0 / 1 | No. 2084 | No. 1 |
![]() |
||
C00022025
![]() |
Solanascone
|
No. 2284 |
![]() |
|||||
C00000091
![]() |
trans-Zeatin
|
CHEMBL525239
|
D015026
|
2 / 3 / 2 | 0 / 1 | No. 2879 |
![]() |
|
C00000094
![]() |
2iP
/ N6-(delta2-Isopentenyl)adenine |
CHEMBL476189
|
C001478
|
5 / 2 / 3 | 18 / 0 | No. 2879 |
![]() |
|
C00011502
![]() |
cis-(+-)-2,3,4,5-Tetrahydro-2,5'-dimethyl-5-(1-methylethenyl)-2,2'-bifuran
|
No. 2939 |
![]() |
|||||
C00011501
![]() |
trans-(+-)-2-Methyl-5-(2-methyl-5-isopropyltetrahydro-2-furyl)furan
|
No. 2939 |
![]() |
|||||
C00011500
![]() |
trans-(+-)-2-Methyl-5-(2-methyl-5-isopropenyltetrahydro-2-furyl)furan
|
No. 2939 |
![]() |
|||||
C00011503
![]() |
cis-(+-)-2-Methyl-5-(2-methyl-5-isopropyltetrahydro-2-furyl)furan
|
No. 2939 |
![]() |
|||||
C00000316
![]() |
4,8,13-Duratriene-1,3-diol
/ 2,7,11-Cembratrien-4,6-diol |
CHEMBL404253
CHEMBL405787 CHEMBL564595 CHEMBL564868 |
C046139
|
1 / 0 / 0 | No. 3050 | No. 42 |
![]() |
|
C00025956
![]() |
Nicotellin
/ Nicotelline / 3,2':4',3''-Terpyridine |
No. 3168 |
![]() |
|||||
C00020300
![]() |
Drim-8-en-7-one
|
No. 3489 |
![]() |
|||||
C00001158
![]() |
2-Carboxyarabinitol 1-phosphate
|
C054549
|
No. 3606 |
![]() |
||||
C00001540
![]() |
6-Hydroxykynurenic acid
|
No. 3632 |
![]() |
|||||
C00000113
![]() |
Indole-3-carboxylic acid
|
CHEMBL387527
|
C012382
|
1 / 3 / 4 | No. 3632 |
![]() |
||
C00000208
![]() |
Nicotinic acid
|
CHEMBL573
CHEMBL2074803 |
D009525
|
100 / 38 / 34 | 48 / 110 | No. 3681 | No. 1 |
![]() |
C00001428
![]() |
Putrescine
|
CHEMBL46257
|
D011700
|
9 / 5 / 4 | 3 / 4 | No. 3767 |
![]() |
|
C00022027
![]() |
3beta-Hydroxysolanascone beta-sophoroside
|
No. 3772 | No. 41 |
![]() |
||||
C00000908
![]() |
GGPP
/ Geranylgeranyl diphosphate / Geranylgeranyl pyrophosphate |
CHEMBL1160059
CHEMBL1160061 CHEMBL1229266 |
C002963
|
3 / 0 / 0 | 34 / 0 | No. 4178 | No. 38 |
![]() |
C00000880
![]() |
ent-CPP
/ ent-Copalyl diphosphate |
No. 4186 | No. 46 |
![]() |
||||
C00000101
![]() |
IAA methyl ester
/ Methyl indole-3-acetate |
No. 4225 |
![]() |
|||||
C00012845
![]() |
1-keto-alpha-Cyperone
|
No. 4452 |
![]() |
|||||
C00010854
![]() |
HCA 168
/ 8-Hydroxycarvotanacetone / 8-Hydroxy-p-menth-6-en-2-one |
C049018
|
No. 4699 |
![]() |
||||
C00022026
![]() |
(+)-Dehydrosolanascone
|
No. 4724 |
![]() |
|||||
C00002719
![]() |
N-Caffeoylputrescine
|
No. 5072 |
![]() |
|||||
C00013203
![]() |
Phytuberol
/ Deacetylphytuberin / Desacetylphytuberin / [3aR-(3aalpha,5abeta,8beta,9alphaR*)]- 5,5a,6,7,8,9-Hexahydro-alpha,alpha,3a,5a-tetramethyl-3aH-furo[3,2-c]isobenzofuran-8-methanol |
No. 5122 | No. 38 |
![]() |
||||
C00001189
![]() |
Isovaleric acid
/ 3-Methylbutanoic acid |
CHEMBL568737
|
C008216
|
4 / 0 | No. 5262 |
![]() |
||
C00001431
![]() |
Spermidine
|
CHEMBL19612
|
D013095
|
26 / 10 / 12 | 5 / 5 | No. 5867 |
![]() |
|
C00003178
![]() |
Rishitin
|
No. 6390 | No. 38 |
![]() |
||||
C00002056
![]() |
Myosmine
|
CHEMBL423429
|
C002398
|
7 / 5 / 4 | 0 / 1 | No. 6790 | No. 1 |
![]() |
C00002058
![]() |
Nicotyrine
|
CHEMBL1522291
|
C008615
|
4 / 1 / 4 | No. 6807 | No. 1 |
![]() |
|
C00025768
![]() |
Anatalline
|
No. 7039 |
![]() |
|||||
C00011534
![]() |
1-Methyl-3-(1-methylethyl)-1,2-cyclopentanedicarboxylic acid
|
No. 7281 |
![]() |
|||||
C00034611
![]() |
N-Methylputrescine
|
No. 8448 |
![]() |
|||||
C00034359
![]() |
1,2-Dihydropyridine
|
No. 8906 |
![]() |
|||||
C00034612
![]() |
N-Methylpyrrolinium
|
C066184
|
No. 8908 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000094 C00000208 C00000894 C00001428 C00001431 C00001434 C00001497 C00002056 C00002057 C00002724 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000094 C00000208 C00000894 C00001428 C00001431 C00001434 C00001497 C00002056 C00002057 C00002724 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000094 C00000208 C00000894 C00001428 C00001431 C00001434 C00001497 C00002056 C00002057 C00002724 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000094 C00000208 C00001428 C00001431 C00001434 C00001497 C00002056 C00002057 C00002724 | 1 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000094 C00000208 C00001428 C00001431 C00001434 C00001497 C00002056 C00002057 C00002724 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000208 C00000894 C00002056 C00002057 C00002058 C00002724 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001431 C00001497 C00002057 C00002061 C00002724 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001434 C00001497 C00002057 C00002686 C00002724 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000208 C00001434 C00002057 C00002058 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000208 C00001431 C00002057 C00002500 | 1 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000091 C00000894 C00001431 C00002724 | 3 / 2 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000208 C00001434 C00001497 C00002057 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000116 C00001434 C00002057 C00002724 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000208 C00002057 C00002724 | 2 / 2 |
P22303 | Acetylcholinesterase | Hydrolase | C00000208 C00002057 C00002500 | 1 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000116 C00000208 C00002057 | 1 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000208 C00002057 C00002724 | 0 / 3 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000208 C00001434 C00002057 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000208 C00002057 C00002724 | 0 / 1 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000208 C00001434 C00002057 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001431 C00001497 C00002057 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001428 C00001497 C00002057 | 2 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000208 C00001434 C00002057 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00000208 C00001434 C00002724 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000208 C00002057 C00002724 | 0 / 1 |
Q9H015 | Solute carrier family 22 member 4 | Unclassified protein | C00001428 C00001431 C00002057 | 1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00001497 C00002057 C00002686 | 11 / 10 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000208 C00002057 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000208 C00002057 | 2 / 2 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002686 C00002724 | 0 / 0 |
O76082 | Solute carrier family 22 member 5 | Unclassified protein | C00000208 C00002057 | 1 / 2 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002057 C00002058 | 1 / 4 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002057 C00002058 | 0 / 1 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002057 C00002724 | 1 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000208 C00002057 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000208 C00002057 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001497 C00002056 | 3 / 1 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000208 C00002057 | 1 / 1 |
P29466 | Caspase-1 | C14 | C00000208 C00002057 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000208 C00002057 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000208 C00002057 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000208 C00002057 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000208 C00002057 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000208 C00002057 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000208 C00002057 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000208 C00002057 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000208 C00002057 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000208 C00002057 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000208 C00002057 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000208 C00002057 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000208 C00002057 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000208 C00002057 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000208 C00002057 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000208 C00002057 | 1 / 1 |
P10275 | Androgen receptor | NR3C4 | C00000113 C00000116 | 3 / 4 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000894 C00002057 | 4 / 3 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00002057 C00002061 | 1 / 1 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000208 C00002057 | 0 / 0 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00002057 C00002061 | 1 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000208 C00002057 | 0 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000208 C00002057 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00001428 C00001434 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000208 C00002057 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000208 C00002057 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000208 C00002057 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000208 C00002057 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000208 C00002057 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000208 C00002057 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000208 C00002057 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000208 C00002057 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000208 C00002057 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000208 C00002057 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000208 C00002057 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000208 C00002057 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000208 C00002057 | 1 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000208 C00002057 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000208 C00002057 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000208 C00002057 | 1 / 0 |
P08246 | Neutrophil elastase | S1A | C00000208 C00002057 | 2 / 1 |
P43166 | Carbonic anhydrase 7 | Lyase | C00001431 C00002500 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00001431 C00002500 | 1 / 2 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000208 C00002057 | 1 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000208 C00002057 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000208 C00002057 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000894 C00002057 | 2 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001431 C00001434 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00001431 C00002500 | 0 / 1 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000208 C00002057 | 2 / 1 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000208 C00002057 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000208 C00002057 | 1 / 0 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00002057 C00002061 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000208 C00002057 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000208 C00002057 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000208 C00002057 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000208 C00002057 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000208 C00002057 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000208 C00002057 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000208 C00002057 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000208 C00002057 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000208 C00002057 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000208 C00002057 | 3 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000208 C00002057 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000208 C00002057 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00002057 C00002724 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000208 C00002057 | 1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001431 C00002500 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000208 C00002057 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000208 C00002057 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000208 C00002057 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000208 C00002057 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000208 C00002057 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000208 C00000894 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00000208 C00002057 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000208 C00002057 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000208 C00002057 | 1 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000894 C00001497 | 1 / 2 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000208 C00002057 | 5 / 9 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000208 C00002057 | 2 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000208 C00002057 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000208 C00002057 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000208 C00002057 | 2 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00000894 C00002057 | 1 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001497 | 0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00002057 | 1 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00000116 | 5 / 3 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002057 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001497 | 1 / 1 |
Q9HBH1 | Peptide deformylase, mitochondrial | Enzyme | C00000100 | 0 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00002724 | 1 / 2 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00002724 | 0 / 0 |
Q6QHF9 | Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | Enzyme | C00001431 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00002724 | 0 / 0 |
P46098 | 5-hydroxytryptamine receptor 3A | NS | C00002057 | 0 / 0 |
Q9BXC0 | Hydroxycarboxylic acid receptor 1 | Hydroxycarboxylic acid receptor | C00000208 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00002724 | 0 / 0 |
O15439 | Multidrug resistance-associated protein 4 | Unclassified protein | C00001497 | 0 / 0 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00001497 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002724 | 3 / 0 |
Q16280 | Cyclic nucleotide-gated olfactory channel | Unclassified protein | C00001497 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002724 | 3 / 3 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00002057 | 1 / 1 |
P51692 | Signal transducer and activator of transcription 5B | Unclassified protein | C00002724 | 1 / 1 |
O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00002057 | 1 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00002057 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000208 | 1 / 1 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001431 | 0 / 0 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000208 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001431 | 0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00001431 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00002724 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00000894 | 1 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001431 | 0 / 0 |
P43235 | Cathepsin K | C1A | C00001434 | 1 / 2 |
P05164 | Myeloperoxidase | Enzyme | C00001434 | 1 / 2 |
P23280 | Carbonic anhydrase 6 | Lyase | C00001431 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001434 | 1 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00001497 | 1 / 2 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001431 | 0 / 0 |
Q96FL8 | Multidrug and toxin extrusion protein 1 | Cation antiporter | C00000208 | 0 / 0 |
P11230 | Acetylcholine receptor subunit beta | CHRN beta | C00002057 | 2 / 1 |
P02708 | Acetylcholine receptor subunit alpha | CHRN alpha | C00002057 | 3 / 2 |
P49019 | Hydroxycarboxylic acid receptor 3 | Hydroxycarboxylic acid receptor | C00000208 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00000894 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00001497 | 1 / 0 |
P07510 | Acetylcholine receptor subunit gamma | CHRN gamma | C00002057 | 2 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002724 | 0 / 0 |
Q07001 | Acetylcholine receptor subunit delta | CHRN delta | C00002057 | 3 / 2 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00002724 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000208 | 0 / 0 |
P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00002057 | 0 / 0 |
Q16773 | Kynurenine--oxoglutarate transaminase 1 | Enzyme | C00000100 | 0 / 0 |
P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00002057 | 1 / 0 |
P28221 | 5-hydroxytryptamine receptor 1D | Serotonin receptor | C00001434 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00000100 | 0 / 0 |
P28222 | 5-hydroxytryptamine receptor 1B | Serotonin receptor | C00001434 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00000116 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00001431 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00002057 | 1 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00000894 | 4 / 2 |
P04054 | Phospholipase A2 | Enzyme | C00000316 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00001431 | 1 / 1 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002724 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000091 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00001431 | 1 / 1 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00002724 | 3 / 3 |
P17707 | S-adenosylmethionine decarboxylase proenzyme | Enzyme | C00001428 | 0 / 0 |
Q9Y694 | Solute carrier family 22 member 7 | Unclassified protein | C00001497 | 0 / 0 |
Q8WZA2 | Rap guanine nucleotide exchange factor 4 | Unclassified protein | C00001497 | 0 / 0 |
O15440 | Multidrug resistance-associated protein 5 | Unclassified protein | C00001497 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00000894 | 2 / 5 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000116 | 0 / 0 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00002057 | 0 / 0 |
Q08493 | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | PDE_4C | C00001497 | 0 / 0 |
Q07343 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE_4B | C00001497 | 0 / 0 |
P27815 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PDE_4A | C00001497 | 0 / 0 |
Q08499 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | PDE_4D | C00001497 | 1 / 0 |
P49356 | Protein farnesyltransferase subunit beta | Enzyme | C00000908 | 0 / 0 |
P49354 | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Enzyme | C00000908 | 0 / 0 |
Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | CHRN alpha | C00002057 | 1 / 1 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001431 | 0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002500 | 0 / 0 |
Q96J66 | ATP-binding cassette sub-family C member 11 | Unclassified protein | C00001497 | 1 / 0 |
Q8WXA8 | 5-hydroxytryptamine receptor 3C | NS | C00002057 | 0 / 0 |
Q70Z44 | 5-hydroxytryptamine receptor 3D | NS | C00002057 | 0 / 0 |
O95264 | 5-hydroxytryptamine receptor 3B | NS | C00002057 | 0 / 0 |
A5X5Y0 | 5-hydroxytryptamine receptor 3E | NS | C00002057 | 0 / 0 |
P53609 | Geranylgeranyl transferase type-1 subunit beta | Enzyme | C00000908 | 0 / 0 |
Q05901 | Neuronal acetylcholine receptor subunit beta-3 | CHRN beta | C00002057 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001497 | 0 / 0 |
P30532 | Neuronal acetylcholine receptor subunit alpha-5 | CHRN alpha | C00002057 | 1 / 0 |
O15244 | Solute carrier family 22 member 2 | Drug uniporter | C00002057 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00001428
C00001431
C00001497
C00002057
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000208
C00000908
C00001497
C00002057
|
153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 |
C00001428
C00001431
C00001497
C00002057
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000208
C00000908
C00001497
C00002057
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000208
C00000908
C00001497
C00002057
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000208
C00000908
C00002057
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000208
C00000908
C00002057
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00000208
C00000908
C00002057
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00000208
C00000908
C00002057
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00000908
C00002057
C00002724
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00001189
C00002057
C00002724
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000908
C00001431
C00002057
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00000208
C00000908
|
338442 | HCAR2, GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g | hydroxycarboxylic acid receptor 2 |
C00000208
C00001497
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00001497
C00002057
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00001497
C00002057
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00001497
C00002057
|
7431 | VIM, CTRCT30 | vimentin |
C00000094
C00002057
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000908
C00002057
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000908
C00002057
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00000908
C00002057
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00000094
C00001497
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000908
C00002057
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00000908
C00002724
|
8843 | HCAR3, GPR109B, HCA3, HM74, PUMAG, Puma-g | hydroxycarboxylic acid receptor 3 |
C00000208
C00001497
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00001497
C00002057
|
3952 | LEP, LEPD, OB, OBS | leptin |
C00000208
C00001497
|
9370 | ADIPOQ, ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1, GBP28 | adiponectin, C1Q and collagen domain containing |
C00000208
C00001497
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00000908
C00002057
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00001434
C00002057
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000208
C00000908
|
3991 | LIPE, HSL, LHS | lipase, hormone-sensitive (EC:3.1.1.79) |
C00000208
C00001497
|
7253 | TSHR, CHNG1, LGR3, hTSHR-I | thyroid stimulating hormone receptor |
C00001497
C00002057
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00002057
C00002724
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00002057
C00002724
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000208
C00002724
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000208
C00002057
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00000908
C00002057
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00000908
C00002057
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00001189
C00002724
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00001189
C00002724
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00000208
C00002057
|
5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00000908
C00002057
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000208
C00002057
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00001189
C00002724
|
56729 | RETN, ADSF, FIZZ3, RETN1, RSTN, XCP1 | resistin |
C00000208
C00000908
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00000908
C00002057
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00001431
C00002057
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00000208
C00000908
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002057
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000908
|
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00000908
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00000908
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00000908
|
8013 | NR4A3, CHN, CSMF, MINOR, NOR1, TEC | nuclear receptor subfamily 4, group A, member 3 |
C00000908
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00000908
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000100
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00000100
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00000908
|
3356 | HTR2A, 5-HT2A, HTR2 | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
C00001434
|
6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001434
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001434
|
6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001434
|
134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001434
|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00001497
|
116 | ADCYAP1, PACAP | adenylate cyclase activating polypeptide 1 (pituitary) |
C00001497
|
9453 | GGPS1, GGPPS, GGPPS1 | geranylgeranyl diphosphate synthase 1 (EC:2.5.1.1 2.5.1.10 2.5.1.29) |
C00000908
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00000908
|
1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor |
C00000908
|
155 | ADRB3, BETA3AR | adrenoceptor beta 3 |
C00001497
|
250 | ALPP, ALP, PALP, PLAP, PLAP-1 | alkaline phosphatase, placental (EC:3.1.3.1) |
C00001497
|
551 | AVP, ADH, ARVP, AVP-NPII, AVRP, VP | arginine vasopressin |
C00001497
|
554 | AVPR2, ADHR, DI1, DIR, DIR3, NDI, V2R | arginine vasopressin receptor 2 |
C00001497
|
673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) |
C00001497
|
796 | CALCA, CALC1, CGRP, CGRP-I, CGRP1, CT, KC | calcitonin-related polypeptide alpha |
C00001497
|
10498 | CARM1, PRMT4 | coactivator-associated arginine methyltransferase 1 (EC:2.1.1.125) |
C00001497
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000094
|
7127 | TNFAIP2, B94, EXOC3L3 | tumor necrosis factor, alpha-induced protein 2 |
C00000094
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001497
|
1081 | CGA, CG-ALPHA, FSHA, GPHA1, GPHa, HCG, LHA, TSHA | glycoprotein hormones, alpha polypeptide |
C00001497
|
1082 | CGB, CGB3, CGB5, CGB7, CGB8, hCGB | chorionic gonadotropin, beta polypeptide |
C00001497
|
1268 | CNR1, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR | cannabinoid receptor 1 (brain) |
C00001497
|
1269 | CNR2, CB-2, CB2, CX5 | cannabinoid receptor 2 (macrophage) |
C00001497
|
1387 | CREBBP, CBP, KAT3A, RSTS | CREB binding protein (EC:2.3.1.48) |
C00001497
|
1392 | CRH, CRF | corticotropin releasing hormone |
C00001497
|
1394 | CRHR1, CRF-R, CRF-R-1, CRF-R1, CRF1, CRFR-1, CRFR1, CRH-R-1, CRH-R1, CRH-R1h, CRHR, CRHR1L, CRHR1f | corticotropin releasing hormone receptor 1 |
C00001497
|
1440 | CSF3, C17orf33, CSF3OS, GCSF, G-CSF | colony stimulating factor 3 (granulocyte) |
C00001497
|
1584 | CYP11B1, CPN1, CYP11B, FHI, P450C11 | cytochrome P450, family 11, subfamily B, polypeptide 1 (EC:1.14.15.4) |
C00001497
|
1586 | CYP17A1, CPT7, CYP17, P450C17, S17AH | cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) |
C00001497
|
27185 | DISC1, C1orf136, SCZD9 | disrupted in schizophrenia 1 |
C00001497
|
22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 |
C00001497
|
1812 | DRD1, DADR, DRD1A | dopamine receptor D1 |
C00001497
|
1813 | DRD2, D2DR, D2R | dopamine receptor D2 |
C00001497
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00001497
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00001497
|
2150 | F2RL1, GPR11, PAR2 | coagulation factor II (thrombin) receptor-like 1 |
C00001497
|
7029 | TFDP2, DP2 | transcription factor Dp-2 (E2F dimerization partner 2) |
C00000094
|
2488 | FSHB | follicle stimulating hormone, beta polypeptide |
C00001497
|
2668 | GDNF, ATF1, ATF2, HFB1-GDNF, HSCR3 | glial cell derived neurotrophic factor |
C00001497
|
2778 | GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, NESP, PHP1A, PHP1B, PHP1C, POH | GNAS complex locus |
C00001497
|
6286 | S100P, MIG9 | S100 calcium binding protein P |
C00000094
|
6016 | RIT1, NS8, RIBB, RIT, ROC1 | Ras-like without CAAX 1 |
C00000094
|
3269 | HRH1, H1-R, hisH1 | histamine receptor H1 |
C00001497
|
3274 | HRH2, H2R | histamine receptor H2 |
C00001497
|
3284 | HSD3B2, HSD3B, HSDB, SDR11E2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) |
C00001497
|
3350 | HTR1A, 5-HT-1A, 5-HT1A, 5HT1a, ADRB2RL1, ADRBRL1, G-21, PFMCD | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
C00001497
|
3351 | HTR1B, 5-HT1B, 5-HT1DB, HTR1D2, HTR1DB, S12 | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
C00001497
|
3363 | HTR7, 5-HT7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
C00001497
|
3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
C00001497
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00001497
|
3624 | INHBA, EDF, FRP | inhibin, beta A |
C00001497
|
6004 | RGS16, A28-RGS14, A28-RGS14P, RGS-R | regulator of G-protein signaling 16 |
C00000094
|
5774 | PTPN3, PTP-H1, PTPH1 | protein tyrosine phosphatase, non-receptor type 3 (EC:3.1.3.48) |
C00000094
|
3972 | LHB, CGB4, LSH-B, hLHB | luteinizing hormone beta polypeptide |
C00001497
|
3973 | LHCGR, HHG, LCGR, LGR2, LH/CG-R, LH/CGR, LHR, LHRHR, LSH-R, ULG5 | luteinizing hormone/choriogonadotropin receptor |
C00001497
|
5782 | PTPN12, PTP-PEST, PTPG1 | protein tyrosine phosphatase, non-receptor type 12 (EC:3.1.3.48) |
C00000094
|
4158 | MC2R, ACTHR | melanocortin 2 receptor (adrenocorticotropic hormone) |
C00001497
|
54539 | NDUFB11, CI-ESSS, ESSS, NP17.3, Np15, P17.3 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa |
C00001497
|
4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00001497
|
10846 | PDE10A, HSPDE10A | phosphodiesterase 10A (EC:3.1.4.35 3.1.4.17) |
C00001497
|
50940 | PDE11A, PPNAD2 | phosphodiesterase 11A (EC:3.1.4.35 3.1.4.17) |
C00001497
|
5150 | PDE7A, HCP1, PDE7 | phosphodiesterase 7A (EC:3.1.4.17) |
C00001497
|
27115 | PDE7B, bA472E5.1 | phosphodiesterase 7B (EC:3.1.4.17) |
C00001497
|
5151 | PDE8A, HsT19550 | phosphodiesterase 8A (EC:3.1.4.17) |
C00001497
|
8622 | PDE8B, ADSD, PPNAD3 | phosphodiesterase 8B (EC:3.1.4.17) |
C00001497
|
5152 | PDE9A, HSPDE9A2 | phosphodiesterase 9A (EC:3.1.4.35) |
C00001497
|
5617 | PRL | prolactin |
C00001497
|
84432 | PROK1, EGVEGF, PK1, PRK1 | prokineticin 1 |
C00001497
|
5739 | PTGIR, IP, PRIPR | prostaglandin I2 (prostacyclin) receptor (IP) |
C00001497
|
5744 | PTHLH, BDE2, HHM, PLP, PTHR, PTHRP | parathyroid hormone-like hormone |
C00001497
|
5908 | RAP1B, K-REV, RAL1B | RAP1B, member of RAS oncogene family |
C00001497
|
9376 | SLC22A8, OAT3 | solute carrier family 22 (organic anion transporter), member 8 |
C00001497
|
6518 | SLC2A5, GLUT-5, GLUT5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
C00001497
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00001497
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00001497
|
7252 | TSHB, TSH-B, TSH-BETA | thyroid stimulating hormone, beta |
C00001497
|
9360 | PPIG, CARS-Cyp, CYP, SCAF10, SRCyp | peptidylprolyl isomerase G (cyclophilin G) (EC:5.2.1.8) |
C00000094
|
7432 | VIP, PHM27 | vasoactive intestinal peptide |
C00001497
|
7434 | VIPR2, C16DUPq36.3, DUP7q36.3, PACAP-R-3, PACAP-R3, VIP-R-2, VPAC2, VPAC2R, VPCAP2R | vasoactive intestinal peptide receptor 2 |
C00001497
|
7474 | WNT5A, hWNT5A | wingless-type MMTV integration site family, member 5A |
C00001497
|
47 | ACLY, ACL, ATPCL, CLATP | ATP citrate lyase (EC:2.3.3.8) |
C00002724
|
358 | AQP1, AQP-CHIP, CHIP28, CO | aquaporin 1 |
C00002724
|
360 | AQP3, AQP-3, GIL | aquaporin 3 (Gill blood group) |
C00002724
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00002724
|
960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00002724
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00000094
|
4512 | COX1, COI, MTCO1, MT-CO1 | cytochrome c oxidase subunit I |
C00002724
|
114757 | CYGB, HGB, STAP | cytoglobin |
C00002724
|
1830 | DSG3, CDHF6, PVA | desmoglein 3 |
C00002724
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00002724
|
2200 | FBN1, ACMICD, ECTOL1, FBN, GPHYSD2, MASS, MFS1, OCTD, SGS, SSKS, WMS, WMS2 | fibrillin 1 |
C00002724
|
2201 | FBN2, CCA, DA9 | fibrillin 2 |
C00002724
|
2246 | FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-1, FGF-alpha, FGFA, GLIO703, HBGF-1, HBGF1 | fibroblast growth factor 1 (acidic) |
C00002724
|
2896 | GRN, CLN11, GEP, GP88, PCDGF, PEPI, PGRN | granulin |
C00002724
|
3036 | HAS1, HAS | hyaluronan synthase 1 (EC:2.4.1.212) |
C00002724
|
3315 | HSPB1, CMT2F, HMN2B, HS.76067, HSP27, HSP28, Hsp25, SRP27 | heat shock 27kDa protein 1 |
C00002724
|
3852 | KRT5, CK5, DDD, DDD1, EBS2, K5, KRT5A | keratin 5 |
C00002724
|
4157 | MC1R, CMM5, MSH-R, SHEP2 | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
C00002724
|
8544 | PIR | pirin (iron-binding nuclear protein) (EC:1.13.11.24) |
C00000094
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00002724
|
8985 | PLOD3, LH3 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (EC:1.14.11.4) |
C00002724
|
440 | ASNS, TS11 | asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) |
C00000094
|
5886 | RAD23A, HHR23A, HR23A | RAD23 homolog A (S. cerevisiae) |
C00002724
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00002724
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00002724
|
6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00002724
|
6716 | SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (EC:1.3.1.22) |
C00002724
|
7178 | TPT1, HRF, TCTP, p02, p23 | tumor protein, translationally-controlled 1 |
C00002724
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00002724
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00002724
|
7306 | TYRP1, CAS2, CATB, GP75, OCA3, TRP, TRP1, TYRP, b-PROTEIN | tyrosinase-related protein 1 (EC:1.14.18.-) |
C00002724
|
19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00000208
|
183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00000208
|
197 | AHSG, A2HS, AHS, FETUA, HSGA | alpha-2-HS-glycoprotein |
C00000208
|
335 | APOA1 | apolipoprotein A-I |
C00000208
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00000208
|
506 | ATP5B, ATPMB, ATPSB | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (EC:3.6.3.14) |
C00000208
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000208
|
1050 | CEBPA, C/EBP-alpha, CEBP | CCAAT/enhancer binding protein (C/EBP), alpha |
C00000208
|
1052 | CEBPD, C/EBP-delta, CELF, CRP3, NF-IL6-beta | CCAAT/enhancer binding protein (C/EBP), delta |
C00000208
|
1376 | CPT2, CPT1, CPTASE, IIAE4 | carnitine palmitoyltransferase 2 (EC:2.3.1.21) |
C00000208
|
84649 | DGAT2, ARAT, GS1999FULL | diacylglycerol O-acyltransferase 2 (EC:2.3.1.20 2.3.1.76) |
C00000208
|
2149 | F2R, CF2R, HTR, PAR-1, PAR1, TR | coagulation factor II (thrombin) receptor |
C00000208
|
2194 | FASN, FAS, OA-519, SDR27X1 | fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) |
C00000208
|
2641 | GCG, GLP1, GLP2, GRPP | glucagon |
C00000208
|
2688 | GH1, GH, GH-N, GHN, IGHD1B, hGH-N | growth hormone 1 |
C00000208
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00000208
|
4018 | LPA, AK38, APOA, LP | lipoprotein, Lp(a) (EC:3.4.21.-) |
C00000208
|
10062 | NR1H3, LXR-a, LXRA, RLD-1 | nuclear receptor subfamily 1, group H, member 3 |
C00000208
|
5175 | PECAM1, CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM | platelet/endothelial cell adhesion molecule 1 |
C00000208
|
7941 | PLA2G7, LDL-PLA2, LP-PLA2, PAFAD, PAFAH | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (EC:3.1.1.47) |
C00000208
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00000208
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00000208
|
5563 | PRKAA2, AMPK, AMPK2, AMPKa2, PRKAA | protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) |
C00000208
|
5729 | PTGDR, AS1, ASRT1, DP, DP1, PTGDR1 | prostaglandin D2 receptor (DP) |
C00000208
|
5730 | PTGDS, L-PGDS, LPGDS, PDS, PGD2, PGDS, PGDS2 | prostaglandin D2 synthase 21kDa (brain) (EC:5.3.99.2) |
C00000208
|
5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000208
|
9818 | NUPL1, PRO2463 | nucleoporin like 1 |
C00000094
|
949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 |
C00000208
|
182 | JAG1, AGS, AHD, AWS, CD339, HJ1, JAGL1 | jagged 1 |
C00000094
|
10681 | GNB5, GB5 | guanine nucleotide binding protein (G protein), beta 5 |
C00000094
|
7448 | VTN, V75, VN, VNT | vitronectin |
C00000208
|
9625 | AATK, AATYK, AATYK1, LMR1, LMTK1, p35BP | apoptosis-associated tyrosine kinase (EC:2.7.11.1) |
C00002057
|
1636 | ACE, ACE1, CD143, DCP, DCP1, ICH, MVCD3 | angiotensin I converting enzyme (EC:3.4.15.1) |
C00002057
|
210 | ALAD, ALADH, PBGS | aminolevulinate dehydratase (EC:4.2.1.24) |
C00002057
|
216 | ALDH1A1, ALDC, ALDH-E1, ALDH1, ALDH11, PUMB1, RALDH1 | aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36) |
C00002057
|
240 | ALOX5, 5-LO, 5-LOX, 5LPG, LOG5 | arachidonate 5-lipoxygenase (EC:1.13.11.34) |
C00002057
|
262 | AMD1, ADOMETDC, AMD, SAMDC | adenosylmethionine decarboxylase 1 (EC:4.1.1.50) |
C00002057
|
269 | AMHR2, AMHR, MISR2, MISRII, MRII | anti-Mullerian hormone receptor, type II (EC:2.7.11.30) |
C00002057
|
327 | APEH, AARE, ACPH, APH, D3F15S2, D3S48E, DNF15S2, OPH | acylaminoacyl-peptide hydrolase (EC:3.4.19.1) |
C00002057
|
351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00002057
|
55082 | ARGLU1 | arginine and glutamate rich 1 |
C00002057
|
8874 | ARHGEF7, BETA-PIX, COOL-1, COOL1, Nbla10314, P50, P50BP, P85, P85COOL1, P85SPR, PAK3, PIXB | Rho guanine nucleotide exchange factor (GEF) 7 |
C00002057
|
408 | ARRB1, ARB1, ARR1 | arrestin, beta 1 |
C00002057
|
546 | ATRX, ATR2, JMS, MRXHF1, RAD54, RAD54L, SFM1, SHS, XH2, XNP, ZNF-HX | alpha thalassemia/mental retardation syndrome X-linked (EC:3.6.4.12) |
C00002057
|
572 | BAD, BBC2, BCL2L8 | BCL2-associated agonist of cell death |
C00002057
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002057
|
597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00002057
|
627 | BDNF, ANON2, BULN2 | brain-derived neurotrophic factor |
C00002057
|
632 | BGLAP, BGP, OC, OCN | bone gamma-carboxyglutamate (gla) protein |
C00002057
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00002057
|
648 | BMI1, FLVI2/BMI1, PCGF4, RNF51 | BMI1 polycomb ring finger oncogene |
C00002057
|
672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00002057
|
689 | BTF3, BETA-NAC, BTF3a, BTF3b, NACB | basic transcription factor 3 |
C00002057
|
695 | BTK, AGMX1, AT, ATK, BPK, IMD1, PSCTK1, XLA | Bruton agammaglobulinemia tyrosine kinase (EC:2.7.10.2) |
C00002057
|
728 | C5AR1, C5A, C5AR, C5R1, CD88 | complement component 5a receptor 1 |
C00002057
|
730 | C7 | complement component 7 |
C00002057
|
811 | CALR, CRT, RO, SSA, cC1qR | calreticulin |
C00002057
|
830 | CAPZA2, CAPPA2, CAPZ | capping protein (actin filament) muscle Z-line, alpha 2 |
C00002057
|
9607 | CARTPT, CART | CART prepropeptide |
C00002057
|
834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00002057
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002057
|
867 | CBL, C-CBL, CBL2, FRA11B, NSLL, RNF55 | Cbl proto-oncogene, E3 ubiquitin protein ligase |
C00002057
|
11335 | CBX3, HECH, HP1-GAMMA, HP1Hs-gamma | chromobox homolog 3 |
C00002057
|
6360 | CCL16, CKb12, HCC-4, ILINCK, LCC-1, LEC, LMC, Mtn-1, NCC-4, NCC4, SCYA16, SCYL4 | chemokine (C-C motif) ligand 16 |
C00002057
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00002057
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00002057
|
891 | CCNB1, CCNB | cyclin B1 |
C00002057
|
894 | CCND2, KIAK0002 | cyclin D2 |
C00002057
|
898 | CCNE1, CCNE | cyclin E1 |
C00002057
|
901 | CCNG2 | cyclin G2 |
C00002057
|
1234 | CCR5, CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
C00002057
|
1235 | CCR6, BN-1, C-C_CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3, CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22 | chemokine (C-C motif) receptor 6 |
C00002057
|
9973 | CCS | copper chaperone for superoxide dismutase |
C00002057
|
920 | CD4, CD4mut | CD4 molecule |
C00002057
|
4179 | CD46, AHUS2, MCP, MIC10, TLX, TRA2.10 | CD46 molecule, complement regulatory protein |
C00002057
|
966 | CD59, 16.3A5, 1F5, EJ16, EJ30, EL32, G344, HRF-20, HRF20, MAC-IP, MACIF, MEM43, MIC11, MIN1, MIN2, MIN3, MIRL, MSK21, p18-20 | CD59 molecule, complement regulatory protein |
C00002057
|
993 | CDC25A, CDC25A2 | cell division cycle 25A (EC:3.1.3.48) |
C00002057
|
990 | CDC6, CDC18L, HsCDC18, HsCDC6 | cell division cycle 6 |
C00002057
|
8621 | CDK13, CDC2L, CDC2L5, CHED, hCDK13 | cyclin-dependent kinase 13 (EC:2.7.11.23 2.7.11.22) |
C00002057
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00002057
|
1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) |
C00002057
|
1051 | CEBPB, C/EBP-beta, CRP2, IL6DBP, LAP, LIP, NF-IL6, TCF5 | CCAAT/enhancer binding protein (C/EBP), beta |
C00002057
|
1062 | CENPE, CENP-E, KIF10, PPP1R61 | centromere protein E, 312kDa |
C00002057
|
1106 | CHD2, EEOC | chromodomain helicase DNA binding protein 2 (EC:3.6.4.12) |
C00002057
|
1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
C00002057
|
1136 | CHRNA3, LNCR2, NACHRA3, PAOD2 | cholinergic receptor, nicotinic, alpha 3 (neuronal) |
C00002057
|
1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00002057
|
1138 | CHRNA5, LNCR2 | cholinergic receptor, nicotinic, alpha 5 (neuronal) |
C00002057
|
8973 | CHRNA6, CHNRA6 | cholinergic receptor, nicotinic, alpha 6 (neuronal) |
C00002057
|
1139 | CHRNA7, CHRNA7-2, NACHRA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) |
C00002057
|
1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00002057
|
1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
C00002057
|
1160 | CKMT2, SMTCK | creatine kinase, mitochondrial 2 (sarcomeric) (EC:2.7.3.2) |
C00002057
|
100196409 |
C00002057
|
||
1164 | CKS2, CKSHS2 | CDC28 protein kinase regulatory subunit 2 |
C00002057
|
23155 | CLCC1, MCLC | chloride channel CLIC-like 1 |
C00002057
|
1182 | CLCN3, CLC3, ClC-3 | chloride channel, voltage-sensitive 3 |
C00002057
|
1192 | CLIC1, G6, NCC27 | chloride intracellular channel 1 |
C00002057
|
1272 | CNTN1, F3, GP135 | contactin 1 |
C00002057
|
1382 | CRABP2, CRABP-II, RBP6 | cellular retinoic acid binding protein 2 |
C00002057
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00002057
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00002057
|
3579 | CXCR2, CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB | chemokine (C-X-C motif) receptor 2 |
C00002057
|
2833 | CXCR3, CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR | chemokine (C-X-C motif) receptor 3 |
C00002057
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00002057
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002057
|
1583 | CYP11A1, CYP11A, CYPXIA1, P450SCC | cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) |
C00002057
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002057
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002057
|
1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) |
C00002057
|
1553 | CYP2A13, CPAD, CYP2A, CYPIIA13 | cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1) |
C00002057
|
1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00002057
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00002057
|
1621 | DBH, DBM | dopamine beta-hydroxylase (dopamine beta-monooxygenase) (EC:1.14.17.1) |
C00002057
|
54876 | DCAF16, C4orf30 | DDB1 and CUL4 associated factor 16 |
C00002057
|
1642 | DDB1, DDBA, UV-DDB1, XAP1, XPCE, XPE, XPE-BF | damage-specific DNA binding protein 1, 127kDa |
C00002057
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002057
|
10521 | DDX17, P72, RH70 | DEAD (Asp-Glu-Ala-Asp) box helicase 17 (EC:3.6.4.13) |
C00002057
|
9191 | DEDD, CASP8IP1, DEDD1, DEFT, FLDED1 | death effector domain containing |
C00002057
|
1677 | DFFB, CAD, CPAN, DFF-40, DFF2, DFF40 | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
C00002057
|
1719 | DHFR, DHFRP1, DYR | dihydrofolate reductase (EC:1.5.1.3) |
C00002057
|
1725 | DHPS, DHS, DS, MIG13 | deoxyhypusine synthase (EC:2.5.1.46) |
C00002057
|
1777 | DNASE2, DNASE2A, DNL, DNL2 | deoxyribonuclease II, lysosomal (EC:3.1.22.1) |
C00002057
|
10059 | DNM1L, DLP1, DRP1, DVLP, DYMPLE, EMPF, HDYNIV | dynamin 1-like (EC:3.6.5.5) |
C00002057
|
1841 | DTYMK, CDC8, PP3731, TMPK, TYMK | deoxythymidylate kinase (thymidylate kinase) (EC:2.7.4.9) |
C00002057
|
1856 | DVL2 | dishevelled segment polarity protein 2 |
C00002057
|
1783 | DYNC1LI2, DNCLI2, LIC2 | dynein, cytoplasmic 1, light intermediate chain 2 |
C00002057
|
1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00002057
|
1870 | E2F2, E2F-2 | E2F transcription factor 2 |
C00002057
|
1871 | E2F3, E2F-3 | E2F transcription factor 3 |
C00002057
|
1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00002057
|
1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00002057
|
1909 | EDNRA, ET-A, ETA, ETA-R, ETAR, ETRA, hET-AR | endothelin receptor type A |
C00002057
|
1938 | EEF2, EEF-2, EF-2, EF2, SCA26 | eukaryotic translation elongation factor 2 |
C00002057
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00002057
|
5610 | EIF2AK2, EIF2AK1, PKR, PRKR | eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) |
C00002057
|
1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00002057
|
27436 | EML4, C2orf2, ELP120, EMAP-4, EMAPL4, ROPP120 | echinoderm microtubule associated protein like 4 |
C00002057
|
2042 | EPHA3, EK4, ETK, ETK1, HEK, HEK4, TYRO4 | EPH receptor A3 (EC:2.7.10.1) |
C00002057
|
2049 | EPHB3, ETK2, HEK2, TYRO6 | EPH receptor B3 (EC:2.7.10.1) |
C00002057
|
2056 | EPO, EP, MVCD2 | erythropoietin |
C00002057
|
7430 | EZR, CVIL, CVL, VIL2 | ezrin |
C00002057
|
2147 | F2, PT, RPRGL2, THPH1 | coagulation factor II (thrombin) (EC:3.4.21.5) |
C00002057
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00002057
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002057
|
2195 | FAT1, CDHF7, CDHR8, FAT, ME5, hFat1 | FAT atypical cadherin 1 |
C00002057
|
9638 | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) |
C00002057
|
2247 | FGF2, BFGF, FGF-2, FGFB, HBGF-2 | fibroblast growth factor 2 (basic) |
C00002057
|
2322 | FLT3, CD135, FLK-2, FLK2, STK1 | fms-related tyrosine kinase 3 (EC:2.7.10.1) |
C00002057
|
2328 | FMO3, FMOII, TMAU, dJ127D3.1 | flavin containing monooxygenase 3 (EC:1.14.13.8 1.14.13.148) |
C00002057
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00002057
|
2348 | FOLR1, FBP, FOLR | folate receptor 1 (adult) |
C00002057
|
2354 | FOSB, AP-1, G0S3, GOS3, GOSB | FBJ murine osteosarcoma viral oncogene homolog B |
C00002057
|
2308 | FOXO1, FKH1, FKHR, FOXO1A | forkhead box O1 |
C00002057
|
2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00002057
|
2582 | GALE, SDR1E1 | UDP-galactose-4-epimerase (EC:5.1.3.2) |
C00002057
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002057
|
2643 | GCH1, DYT14, DYT5, DYT5a, GCH, GTP-CH-1, GTPCH1, HPABH4B | GTP cyclohydrolase 1 (EC:3.5.4.16) |
C00002057
|
2657 | GDF1, DORV, DTGA3, RAI | growth differentiation factor 1 |
C00002057
|
11010 | GLIPR1, CRISP7, GLIPR, RTVP1 | GLI pathogenesis-related 1 |
C00002057
|
2790 | GNG10 | guanine nucleotide binding protein (G protein), gamma 10 |
C00002057
|
2803 | GOLGA4, GCP2, GOLG, MU-RMS-40.18, p230 | golgin A4 |
C00002057
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00002057
|
30206 |
C00002057
|
||
2931 | GSK3A | glycogen synthase kinase 3 alpha (EC:2.7.11.1 2.7.11.26) |
C00002057
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00002057
|
2978 | GUCA1A, C6orf131, COD3, CORD14, GCAP, GCAP1, GUCA, GUCA1, dJ139D8.6 | guanylate cyclase activator 1A (retina) |
C00002057
|
3094 | HINT1, HINT, NMAN, PKCI-1, PRKCNH1 | histidine triad nucleotide binding protein 1 |
C00002057
|
6596 | HLTF, HIP116, HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3, ZBU1 | helicase-like transcription factor |
C00002057
|
3159 | HMGA1, HMG-R, HMGA1A, HMGIY | high mobility group AT-hook 1 |
C00002057
|
50809 | HP1BP3, HP1-BP74 | heterochromatin protein 1, binding protein 3 |
C00002057
|
3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00002057
|
3422 | IDI1, IPP1, IPPI1 | isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2) |
C00002057
|
2537 | IFI6, 6-16, FAM14C, G1P3, IFI-6-16, IFI616 | interferon, alpha-inducible protein 6 |
C00002057
|
3454 | IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC | interferon (alpha, beta and omega) receptor 1 |
C00002057
|
3507 |
C00002057
|
||
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00002057
|
3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00002057
|
3563 | IL3RA, CD123, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | interleukin 3 receptor, alpha (low affinity) |
C00002057
|
3574 | IL7, IL-7 | interleukin 7 |
C00002057
|
3578 | IL9, HP40, IL-9, P40 | interleukin 9 |
C00002057
|
3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00002057
|
3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
C00002057
|
3683 | ITGAL, CD11A, LFA-1, LFA1A | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
C00002057
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00002057
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00002057
|
3713 | IVL | involucrin |
C00002057
|
80853 | KDM7A, JHDM1D | lysine (K)-specific demethylase 7A |
C00002057
|
3726 | JUNB, AP-1 | jun B proto-oncogene |
C00002057
|
8462 | KLF11, FKLF, FKLF1, MODY7, TIEG2, Tieg3 | Kruppel-like factor 11 |
C00002057
|
58508 | KMT2C, HALR, MLL3 | lysine (K)-specific methyltransferase 2C (EC:2.1.1.43) |
C00002057
|
3912 | LAMB1, CLM, LIS5 | laminin, beta 1 |
C00002057
|
3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) |
C00002057
|
3936 | LCP1, CP64, L-PLASTIN, LC64P, LPL, PLS2 | lymphocyte cytosolic protein 1 (L-plastin) |
C00002057
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00002057
|
3981 | LIG4 | ligase IV, DNA, ATP-dependent (EC:6.5.1.1) |
C00002057
|
9516 | LITAF, PIG7, SIMPLE, TP53I7 | lipopolysaccharide-induced TNF factor |
C00002057
|
9208 | LRRFIP1, FLAP-1, FLAP1, FLIIAP1, GCF-2, GCF2, HUFI-1, TRIP | leucine rich repeat (in FLII) interacting protein 1 |
C00002057
|
4050 | LTB, TNFC, TNFSF3, p33 | lymphotoxin beta (TNF superfamily, member 3) |
C00002057
|
116068 | LYSMD3 | LysM, putative peptidoglycan-binding, domain containing 3 |
C00002057
|
8567 | MADD, DENN, IG20, RAB3GEP | MAP-kinase activating death domain |
C00002057
|
378938 | MALAT1, HCN, LINC00047, MALAT-1, NCRNA00047, NEAT2, PRO2853 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
C00002057
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002057
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002057
|
80306 | MED28, 1500003D12Rik, EG1, magicin | mediator complex subunit 28 |
C00002057
|
4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) |
C00002057
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002057
|
4314 | MMP3, CHDS6, MMP-3, SL-1, STMY, STMY1, STR1 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) |
C00002057
|
4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00002057
|
4485 | MST1, D3F15S2, DNF15S2, HGFL, MSP, NF15S2 | macrophage stimulating 1 (hepatocyte growth factor-like) |
C00002057
|
4528 | MTIF2 | mitochondrial translational initiation factor 2 |
C00002057
|
4605 | MYBL2, B-MYB, BMYB | v-myb avian myeloblastosis viral oncogene homolog-like 2 |
C00002057
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002057
|
4637 | MYL6, ESMLC, LC17, LC17-GI, LC17-NM, LC17A, LC17B, MLC-3, MLC1SM, MLC3NM, MLC3SM | myosin, light chain 6, alkali, smooth muscle and non-muscle |
C00002057
|
79923 | NANOG | Nanog homeobox |
C00002057
|
4698 | NDUFA5, B13, CI-13KD-B, CI-13kB, NUFM, UQOR13 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (EC:1.6.5.3 1.6.99.3) |
C00002057
|
4741 | NEFM, NEF3, NF-M, NFM | neurofilament, medium polypeptide |
C00002057
|
4773 | NFATC2, NFAT1, NFATP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
C00002057
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002057
|
4794 | NFKBIE, IKBE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
C00002057
|
4801 | NFYB, CBF-A, CBF-B, HAP3, NF-YB | nuclear transcription factor Y, beta |
C00002057
|
51199 | NIN, SCKL7 | ninein (GSK3B interacting protein) |
C00002057
|
4832 | NME3, DR-nm23, NDPK-C, NDPKC, NM23-H3, NM23H3, c371H6.2 | NME/NM23 nucleoside diphosphate kinase 3 (EC:2.7.4.6) |
C00002057
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00002057
|
4915 | NTRK2, GP145-TrkB, TRKB, trk-B | neurotrophic tyrosine kinase, receptor, type 2 (EC:2.7.10.1) |
C00002057
|
8473 | OGT, HRNT1, O-GLCNAC | O-linked N-acetylglucosamine (GlcNAc) transferase (EC:2.4.1.255) |
C00002057
|
4986 | OPRK1, K-OR-1, KOR, KOR-1, OPRK | opioid receptor, kappa 1 |
C00002057
|
4999 | ORC2, ORC2L | origin recognition complex, subunit 2 |
C00002057
|
79646 | PANK3 | pantothenate kinase 3 (EC:2.7.1.33) |
C00002057
|
5071 | PARK2, AR-JP, LPRS2, PDJ, PRKN | parkin RBR E3 ubiquitin protein ligase |
C00002057
|
3355109 |
C00002057
|
||
5111 | PCNA | proliferating cell nuclear antigen |
C00002057
|
5159 | PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1 | platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1) |
C00002057
|
51317 | PHF21A, BHC80 | PHD finger protein 21A |
C00002057
|
23469 | PHF3 | PHD finger protein 3 |
C00002057
|
35178 |
C00002057
|
||
5281 | PIGF | phosphatidylinositol glycan anchor biosynthesis, class F (EC:2.7.8.1) |
C00002057
|
5290 | PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) |
C00002057
|
5586 | PKN2, PAK2, PRK2, PRKCL2, PRO2042, Pak-2 | protein kinase N2 (EC:2.7.11.13) |
C00002057
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00002057
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00002057
|
5329 | PLAUR, CD87, U-PAR, UPAR, URKR | plasminogen activator, urokinase receptor |
C00002057
|
5337 | PLD1 | phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4) |
C00002057
|
5338 | PLD2 | phospholipase D2 (EC:3.1.4.4) |
C00002057
|
57480 | PLEKHG1, ARHGEF41 | pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
C00002057
|
5409 | PNMT, PENT, PNMTase | phenylethanolamine N-methyltransferase (EC:2.1.1.28) |
C00002057
|
8228 | PNPLA4, DXS1283E, GS2, iPLA2eta | patatin-like phospholipase domain containing 4 (EC:3.1.1.3) |
C00002057
|
5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00002057
|
5450 | POU2AF1, BOB1, OBF-1, OBF1, OCAB | POU class 2 associating factor 1 |
C00002057
|
5451 | POU2F1, OCT1, OTF1, oct-1B | POU class 2 homeobox 1 |
C00002057
|
5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 |
C00002057
|
5523 | PPP2R3A, PPP2R3, PR130, PR72 | protein phosphatase 2, regulatory subunit B'', alpha (EC:3.1.3.16) |
C00002057
|
5577 | PRKAR2B, PRKAR2, RII-BETA | protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1) |
C00002057
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00002057
|
5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00002057
|
5589 | PRKCSH, AGE-R2, G19P1, PCLD, PKCSH, PLD1 | protein kinase C substrate 80K-H (EC:2.7.11.1) |
C00002057
|
5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) |
C00002057
|
55119 | PRPF38B, NET1, RP11-293A10.1 | pre-mRNA processing factor 38B |
C00002057
|
23215 | PRRC2C, BAT2-iso, BAT2D1, BAT2L2, XTP2 | proline-rich coiled-coil 2C |
C00002057
|
5644 | PRSS1, TRP1, TRY1, TRY4, TRYP1 | protease, serine, 1 (trypsin 1) (EC:3.4.21.4) |
C00002057
|
5694 | PSMB6, DELTA, LMPY, Y | proteasome (prosome, macropain) subunit, beta type, 6 (EC:3.4.25.1) |
C00002057
|
5724 | PTAFR, PAFR | platelet-activating factor receptor |
C00002057
|
58155 | PTBP2, PTB, PTBLP, brPTB, nPTB, nPTB5, nPTB6, nPTB7, nPTB8 | polypyrimidine tract binding protein 2 |
C00002057
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002057
|
5786 | PTPRA, HEPTP, HLPR, HPTPA, HPTPalpha, LRP, PTPA, PTPRL2, R-PTP-alpha, RPTPA | protein tyrosine phosphatase, receptor type, A (EC:3.1.3.48) |
C00002057
|
5806 | PTX3, TNFAIP5, TSG-14 | pentraxin 3, long |
C00002057
|
5870 | RAB6A, RAB6 | RAB6A, member RAS oncogene family |
C00002057
|
10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00002057
|
5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) |
C00002057
|
5916 | RARG, NR1B3, RARC | retinoic acid receptor, gamma |
C00002057
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002057
|
5930 | RBBP6, MY038, P2P-R, PACT, RBQ-1, SNAMA | retinoblastoma binding protein 6 |
C00002057
|
146713 | RBFOX3, FOX-3, FOX3, HRNBP3, NEUN | RNA binding protein, fox-1 homolog (C. elegans) 3 |
C00002057
|
5933 | RBL1, CP107, PRB1, p107 | retinoblastoma-like 1 (p107) |
C00002057
|
5934 | RBL2, P130, Rb2 | retinoblastoma-like 2 (p130) |
C00002057
|
58517 | RBM25, NET52, RED120, RNPC7, S164, Snu71, fSAP94 | RNA binding motif protein 25 |
C00002057
|
5994 | RFXAP | regulatory factor X-associated protein |
C00002057
|
5996 | RGS1, 1R20, BL34, IER1, IR20 | regulator of G-protein signaling 1 |
C00002057
|
6018 | RLF, ZN-15L, ZNF292L | rearranged L-myc fusion |
C00002057
|
6130 | RPL7A, L7A, SURF3, TRUP | ribosomal protein L7a |
C00002057
|
6230 | RPS25, S25 | ribosomal protein S25 |
C00002057
|
57521 | RPTOR, KOG1, Mip1 | regulatory associated protein of MTOR, complex 1 |
C00002057
|
862 | RUNX1T1, AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
C00002057
|
6281 | S100A10, 42C, ANX2L, ANX2LG, CAL1L, CLP11, Ca[1], GP11, P11, p10 | S100 calcium binding protein A10 |
C00002057
|
44263 |
C00002057
|
||
66234 |
C00002057
|
||
9169 | SCAF11, CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP | SR-related CTD-associated factor 11 |
C00002057
|
23480 | SEC61G, SSS1 | Sec61 gamma subunit |
C00002057
|
10955 | SERINC3, AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1 | serine incorporator 3 |
C00002057
|
871 | SERPINH1, AsTP3, CBP1, CBP2, HSP47, OI10, PPROM, RA-A47, SERPINH2, gp46 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
C00002057
|
51639 | SF3B14, HSPC175, Ht006, P14, SAP14, SF3B14a | splicing factor 3B, 14 kDa subunit |
C00002057
|
10572 | SIVA1, CD27BP, SIVA, Siva-1, Siva-2 | SIVA1, apoptosis-inducing factor |
C00002057
|
6573 | SLC19A1, CHMD, FOLT, IFC1, REFC, RFC1 | solute carrier family 19 (folate transporter), member 1 |
C00002057
|
10559 | SLC35A1, CDG2F, CMPST, CST, hCST | solute carrier family 35 (CMP-sialic acid transporter), member A1 |
C00002057
|
25800 | SLC39A6, LIV-1 | solute carrier family 39 (zinc transporter), member 6 |
C00002057
|
9351 | SLC9A3R2, E3KARP, NHE3RF2, NHERF-2, NHERF2, OCTS2, SIP-1, SIP1, TKA-1 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
C00002057
|
4093 | SMAD9, MADH6, MADH9, PPH2, SMAD8, SMAD8A, SMAD8B | SMAD family member 9 |
C00002057
|
6615 | SNAI1, SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1 | snail family zinc finger 1 |
C00002057
|
6591 | SNAI2, SLUG, SLUGH1, SNAIL2, WS2D | snail family zinc finger 2 |
C00002057
|
6619 | SNAPC3, PTFbeta, SNAP50 | small nuclear RNA activating complex, polypeptide 3, 50kDa |
C00002057
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000908
|
252672 |
C00002057
|
||
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00002057
|
6654 | SOS1, GF1, GGF1, GINGF, HGF, NS4 | son of sevenless homolog 1 (Drosophila) |
C00002057
|
9043 | SPAG9, CT89, HLC-6, HLC4, JIP-4, JIP4, JLP, PHET, PIG6 | sperm associated antigen 9 |
C00002057
|
6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00002057
|
6714 | SRC, ASV, SRC1, c-SRC, p60-Src | v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) |
C00002057
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00002057
|
400410 | ST20, HCCS-1 | suppressor of tumorigenicity 20 |
C00002057
|
6770 | STAR, STARD1 | steroidogenic acute regulatory protein |
C00002057
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00002057
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00002057
|
6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00002057
|
6778 | STAT6, D12S1644, IL-4-STAT, STAT6B, STAT6C | signal transducer and activator of transcription 6, interleukin-4 induced |
C00002057
|
8614 | STC2, STC-2, STCRP | stanniocalcin 2 |
C00002057
|
10963 | STIP1, HOP, IEF-SSP-3521, P60, STI1, STI1L | stress-induced-phosphoprotein 1 |
C00002057
|
10494 | STK25, SOK1, YSK1 | serine/threonine kinase 25 (EC:2.7.11.1) |
C00002057
|
6814 | STXBP3, MUNC18-3, MUNC18C, PSP, UNC-18C | syntaxin binding protein 3 |
C00002057
|
6827 | SUPT4H1, SPT4, SPT4H, SUPT4H | suppressor of Ty 4 homolog 1 (S. cerevisiae) |
C00002057
|
8407 | TAGLN2, HA1756 | transgelin 2 |
C00002057
|
57551 | TAOK1, KFC-B, MAP3K16, MARKK, PSK-2, PSK2, TAO1, hKFC-B, hTAOK1 | TAO kinase 1 (EC:2.7.11.1) |
C00002057
|
7027 | TFDP1, DP1, DRTF1, Dp-1 | transcription factor Dp-1 |
C00002057
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00002057
|
7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00002057
|
7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) |
C00002057
|
9984 | THOC1, HPR1, P84, P84N5 | THO complex 1 |
C00002057
|
7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00002057
|
7078 | TIMP3, HSMRK222, K222, K222TA2, SFD | TIMP metallopeptidase inhibitor 3 |
C00002057
|
7079 | TIMP4 | TIMP metallopeptidase inhibitor 4 |
C00002057
|
7082 | TJP1, ZO-1 | tight junction protein 1 |
C00002057
|
440026 | TMEM41B | transmembrane protein 41B |
C00002057
|
7132 | TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60 | tumor necrosis factor receptor superfamily, member 1A |
C00002057
|
11073 | TOPBP1, TOP2BP1 | topoisomerase (DNA) II binding protein 1 |
C00002057
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002057
|
7175 | TPR | translocated promoter region, nuclear basket protein |
C00002057
|
29896 | TRA2A, AWMS1, HSU53209 | transformer 2 alpha homolog (Drosophila) |
C00002057
|
28951 | TRIB2, C5FW, GS3955, TRB2 | tribbles pseudokinase 2 |
C00002057
|
9321 | TRIP11, ACG1A, CEV14, GMAP-210, TRIP-11, TRIP230 | thyroid hormone receptor interactor 11 |
C00002057
|
7277 | TUBA4A, H2-ALPHA, TUBA1 | tubulin, alpha 4a |
C00002057
|
203068 | TUBB, M40, OK/SW-cl.56, TUBB1, TUBB5 | tubulin, beta class I |
C00002057
|
7291 | TWIST1, ACS3, BPES2, BPES3, CRS1, SCS, TWIST, bHLHa38 | twist family bHLH transcription factor 1 |
C00002057
|
10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 |
C00002057
|
23350 | U2SURP, SR140, fSAPa | U2 snRNP-associated SURP domain containing |
C00002057
|
10054 | UBA2, ARX, SAE2 | ubiquitin-like modifier activating enzyme 2 |
C00002057
|
11065 | UBE2C, UBCH10, dJ447F3.2 | ubiquitin-conjugating enzyme E2C (EC:6.3.2.19) |
C00002057
|
7329 | UBE2I, C358B7.1, P18, UBC9 | ubiquitin-conjugating enzyme E2I (EC:6.3.2.19) |
C00002057
|
7337 | UBE3A, ANCR, AS, E6-AP, EPVE6AP, HPVE6A | ubiquitin protein ligase E3A (EC:6.3.2.19) |
C00002057
|
51569 | UFM1, BM-002, C13orf20 | ubiquitin-fold modifier 1 |
C00002057
|
7360 | UGP2, UDPG, UDPGP, UDPGP2, UGP1, UGPP1, UGPP2, pHC379 | UDP-glucose pyrophosphorylase 2 (EC:2.7.7.9) |
C00002057
|
54657 | UGT1A4, HUG-BR2, UDPGT, UDPGT_1-4, UGT-1D, UGT1-04, UGT1.4, UGT1D | UDP glucuronosyltransferase 1 family, polypeptide A4 (EC:2.4.1.17) |
C00002057
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002057
|
9094 | UNC119, HRG4, POC7, POC7A | unc-119 homolog (C. elegans) |
C00002057
|
7386 | UQCRFS1, RIP1, RIS1, RISP, UQCR5 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (EC:1.10.2.2) |
C00002057
|
7450 | VWF, F8VWF, VWD | von Willebrand factor |
C00002057
|
694 | BTG1 | B-cell translocation gene 1, anti-proliferative |
C00000094
|
7503 | XIST, DXS1089, DXS399E, LINC00001, NCRNA00001, SXI1, swd66 | X inactive specific transcript (non-protein coding) |
C00002057
|
7525 | YES1, HsT441, P61-YES, Yes, c-yes | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 (EC:2.7.10.2) |
C00002057
|
23318 | ZCCHC11, PAPD3, TUT4 | zinc finger, CCHC domain containing 11 (EC:2.7.7.52) |
C00002057
|
84240 | ZCCHC9, PPP1R41 | zinc finger, CCHC domain containing 9 |
C00002057
|
6935 | ZEB1, AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3, TCF8, ZFHEP, ZFHX1A | zinc finger E-box binding homeobox 1 |
C00002057
|
7538 | ZFP36, G0S24, GOS24, NUP475, RNF162A, TIS11, TTP, zfp-36 | ZFP36 ring finger protein |
C00002057
|
51663 | ZFR, ZFR1 | zinc finger RNA binding protein |
C00002057
|
23613 | ZMYND8, PRKCBP1, PRO2893, RACK7 | zinc finger, MYND-type containing 8 |
C00002057
|
7705 | ZNF146, OZF | zinc finger protein 146 |
C00002057
|
100129482 | ZNF37BP, KOX21, ZNF37B | zinc finger protein 37B, pseudogene |
C00002057
|
90333 | ZNF468 | zinc finger protein 468 |
C00002057
|
100289635 | ZNF605 | zinc finger protein 605 |
C00002057
|
100129842 | ZNF737, ZNF102 | zinc finger protein 737 |
C00002057
|
26 | AOC1, ABP, ABP1, DAO, DAO1, KAO | amine oxidase, copper containing 1 (EC:1.4.3.22) |
C00001428
|
486 | FXYD2, ATP1G1, HOMG2 | FXYD domain containing ion transport regulator 2 |
C00001431
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#614613 | Acrodysostosis 2, with or without hormone resistance; acrdys2 |
Q08499
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#117800 | Apocrine gland secretion, variation in |
Q96J66
|
#600807 | Asthma, susceptibility to |
Q13093
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#212140 | Carnitine deficiency, systemic primary; cdsp |
O76082
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#162800 | Cyclic neutropenia |
P08246
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#610353 | Epilepsy, nocturnal frontal lobe, 4; enfl4 |
Q15822
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#245590 | Growth hormone insensitivity with immunodeficiency |
P51692
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#265000 | Multiple pterygium syndrome, escobar variant; evmps |
P07510
|
#253290 | Multiple pterygium syndrome, lethal type; lmps |
P02708
P07510 Q07001 |
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency |
P11230
|
#608930 | Myasthenic syndrome, congenital, fast-channel |
P02708
Q07001 |
#601462 | Myasthenic syndrome, congenital, slow-channel; sccms |
P02708
P11230 Q07001 |
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#254600 | Myeloperoxidase deficiency; mpod |
P05164
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#265800 | Pycnodysostosis |
P43235
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#180300 | Rheumatoid arthritis; ra |
Q9H015
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#612052 | Smoking as a quantitative trait locus 3; sqtl3 |
P30532
P32297 |
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00286 | Crohn's disease |
O76082
(related)
Q9H015 (related) |
H00525 | Disorders of fatty-acid oxidation |
O76082
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00770 | Congenital myasthenic syndrome |
P02708
(related)
P11230 (related) Q07001 (related) |
H00986 | Multiple pterygium syndrome |
P02708
(related)
P07510 (related) Q07001 (related) |
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00101 | Other phagocyte defects |
P05164
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P05164
(marker)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) Q15822 (related) |
H00548 | Brunner syndrome |
P21397
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00273 | Pycnodysostosis |
P43235
(related)
|
H00425 | Lysosomal cysteine protease deficiencies |
P43235
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00931 | Growth hormone insensitivity with immunodeficiency |
P51692
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D056486 | Drug-Induced Liver Injury |
C00000100
C00002724 C00000208 C00002057 C00001428 C00001431 |
D006948 | Hyperkinesis |
C00002056
C00002017 C00002057 C00001431 |
D006973 | Hypertension |
C00001497
C00000208 C00002057 C00001428 |
D012640 | Seizures |
C00001434
C00002057 C00001431 |
D009336 | Necrosis |
C00002724
C00000208 C00002057 |
D000647 | Amnesia |
C00002724
C00002057 C00000091 |
D014202 | Tremor |
C00001434
C00001497 C00002057 |
D001161 | Arteriosclerosis |
C00000208
C00002057 |
D011041 | Poisoning |
C00002057
C00001431 |
D013375 | Substance Withdrawal Syndrome |
C00001497
C00002057 |
D004409 | Dyskinesia, Drug-Induced |
C00001497
C00002057 |
D006937 | Hypercholesterolemia |
C00002724
C00000208 |
D006951 | Hyperlipoproteinemias |
C00002724
C00000208 |
D015228 | Hypertriglyceridemia |
C00002724
C00000208 |
D052456 | Hypoalphalipoproteinemias |
C00002724
C00000208 |
D008545 | Melanoma |
C00002724
C00002057 |
D006332 | Cardiomegaly |
C00001428
C00001431 |
D014839 | Vomiting |
C00000208
C00002057 |
D020521 | Stroke |
C00000208
C00002057 |
D012164 | Retinal Diseases |
C00000208
C00002057 |
D000544 | Alzheimer Disease |
C00000208
C00002057 |
D011537 | Pruritus |
C00000208
C00002057 |
D011507 | Proteinuria |
C00000208
C00002057 |
D006930 | Hyperalgesia |
C00001497
C00002057 |
D050197 | Atherosclerosis |
C00000208
C00002057 |
D001943 | Breast Neoplasms |
C00000208
C00002057 |
D002318 | Cardiovascular Diseases |
C00000208
C00002057 |
D010523 | Peripheral Nervous System Diseases |
C00000208
C00002057 |
D010146 | Pain |
C00000208
C00002057 |
D009369 | Neoplasms |
C00000208
C00002057 |
D009325 | Nausea |
C00000208
C00002057 |
D015428 | Myocardial Reperfusion Injury |
C00000208
C00002057 |
D009203 | Myocardial Infarction |
C00000208
C00002057 |
D007333 | Insulin Resistance |
C00000208
C00002057 |
D007249 | Inflammation |
C00000208
C00002057 |
D007022 | Hypotension |
C00000208
C00002057 |
D003072 | Cognition Disorders |
C00000208
C00002057 |
D003324 | Coronary Artery Disease |
C00000208
C00002057 |
D018476 | Hypokinesia |
C00000208
C00002057 |
D005234 | Fatty Liver |
C00000208
C00002057 |
D003693 | Delirium |
C00000208
C00002057 |
D005076 | Exanthema |
C00000208
C00002057 |
D004890 | Erythema |
C00000208
C00002057 |
D004244 | Dizziness |
C00000208
C00002057 |
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00000208
C00002057 |
D004487 | Edema |
C00000208
C00002057 |
D015427 | Reperfusion Injury |
C00002057
|
D004415 | Dyspepsia |
C00000208
|
D020820 | Dyskinesias |
C00000208
|
D019446 | Endotoxemia |
C00000208
|
D003925 | Diabetic Angiopathies |
C00000208
|
D003920 | Diabetes Mellitus |
C00000208
|
D005094 | Exophthalmos |
C00000208
|
D005128 | Eye Diseases |
C00000208
|
D005141 | Eyelid Diseases |
C00000208
|
D023921 | Coronary Stenosis |
C00000208
|
D005483 | Flushing |
C00000208
|
D005767 | Gastrointestinal Diseases |
C00000208
|
D005923 | Glomerulosclerosis, Focal Segmental |
C00000208
|
D018149 | Glucose Intolerance |
C00000208
|
D006073 | Gout |
C00000208
|
D006501 | Hepatic Encephalopathy |
C00000208
|
D006505 | Hepatitis |
C00000208
|
D006943 | Hyperglycemia |
C00000208
|
D020138 | HYPERHOMOCYSTEINEMIA |
C00000208
|
D006950 | Hyperlipidemia, Familial Combined |
C00000208
|
D006949 | Hyperlipidemias |
C00000208
|
D006938 | Hyperlipoproteinemia Type II |
C00000208
|
D006952 | Hyperlipoproteinemia Type III |
C00000208
|
D006954 | Hyperlipoproteinemia Type V |
C00000208
|
D007003 | Hypoglycemia |
C00000208
|
D003327 | Coronary Disease |
C00000208
|
D007009 | Hypolipoproteinemias |
C00000208
|
D002972 | Cleft Palate |
C00000208
|
D020244 | Infarction, Middle Cerebral Artery |
C00000208
|
D002971 | Cleft Lip |
C00000208
|
D043171 | Chromosomal Instability |
C00000208
|
D002546 | Ischemic Attack, Transient |
C00000208
|
D007565 | Jaundice |
C00000208
|
D007634 | Keratitis |
C00000208
|
D007662 | Ketosis |
C00000208
|
D007676 | Kidney Failure, Chronic |
C00000208
|
D007938 | Leukemia |
C00000208
|
D015470 | Leukemia, Myeloid, Acute |
C00000208
|
D008060 | Lipodystrophy |
C00000208
|
D017114 | Liver Failure, Acute |
C00000208
|
D055370 | Lung Injury |
C00000208
|
D008269 | Macular Edema |
C00000208
|
D047508 | Massive Hepatic Necrosis |
C00000208
|
D024821 | Metabolic Syndrome X |
C00000208
|
D008881 | Migraine Disorders |
C00000208
|
D009127 | Muscle Rigidity |
C00000208
|
D009135 | Muscular Diseases |
C00000208
|
D002780 | Cholestasis, Intrahepatic |
C00000208
|
D017202 | Myocardial Ischemia |
C00000208
|
D002779 | Cholestasis |
C00000208
|
D023341 | Chills |
C00000208
|
D002418 | Cattle Diseases |
C00000208
|
D009798 | Ocular Hypertension |
C00000208
|
D002386 | Cataract |
C00000208
|
D010292 | Paresthesia |
C00000208
|
D010383 | Pellagra |
C00000208
|
D002340 | Carotid Artery Diseases |
C00000208
|
D010612 | Pharyngitis |
C00000208
|
D011014 | Pneumonia |
C00000208
|
D000749 | Anemia, Megaloblastic |
C00000208
|
D000550 | Amblyopia |
C00000208
|
D012162 | Retinal Degeneration |
C00000208
|
D000140 | Acidosis, Lactic |
C00000208
|
D012817 | Signs and Symptoms, Digestive |
C00000208
|
D012859 | Sjogren's Syndrome |
C00000208
|
D012871 | Skin Diseases |
C00000208
|
D012877 | Skin Manifestations |
C00000208
|
D016135 | Spinal Dysraphism |
C00000208
|
D000138 | Acidosis |
C00000208
|
D013575 | Syncope |
C00000208
|
D018781 | Tension-Type Headache |
C00000208
|
D014098 | Toothache |
C00000208
|
D014786 | Vision Disorders |
C00000208
|
D015431 | Weight Loss |
C00002724
|
D014947 | Wounds and Injuries |
C00000208
|
D015746 | Abdominal Pain |
C00002057
|
D000014 | Abnormalities, Drug-Induced |
C00002057
|
D058186 | Acute Kidney Injury |
C00002057
|
D000405 | Akinetic Mutism |
C00002057
|
D000437 | Alcoholism |
C00002057
|
D019969 | Amphetamine-Related Disorders |
C00002057
|
D017542 | Aneurysm, Ruptured |
C00002057
|
D000860 | Anoxia |
C00002057
|
D001008 | Anxiety Disorders |
C00002057
|
D001014 | Aortic Aneurysm |
C00002057
|
D001018 | Aortic Diseases |
C00002057
|
D001049 | Apnea |
C00002057
|
D001145 | Arrhythmias, Cardiac |
C00002057
|
D001168 | Arthritis |
C00002057
|
D001176 | Arthrogryposis |
C00002057
|
D001259 | Ataxia |
C00002057
|
D001281 | Atrial Fibrillation |
C00002057
|
D054537 | Atrioventricular Block |
C00002057
|
D001289 | Attention Deficit Disorder with Hyperactivity |
C00002057
|
D001308 | Auditory Perceptual Disorders |
C00002057
|
D001714 | Bipolar Disorder |
C00002057
|
D001919 | Bradycardia |
C00002057
|
D001927 | Brain Diseases |
C00002057
|
D001929 | Brain Edema |
C00002057
|
D001930 | Brain Injuries |
C00002057
|
D002114 | Calcinosis |
C00002057
|
D002289 | Carcinoma, Non-Small-Cell Lung |
C00002057
|
D002294 | Carcinoma, Squamous Cell |
C00002057
|
D005117 | Cardiac Complexes, Premature |
C00002057
|
D009202 | Cardiomyopathies |
C00002057
|
D002375 | Catalepsy |
C00002057
|
D002543 | Cerebral Hemorrhage |
C00002057
|
D002561 | Cerebrovascular Disorders |
C00002057
|
D018290 | Cervical Intraepithelial Neoplasia |
C00002057
|
D002637 | Chest Pain |
C00002057
|
D019970 | Cocaine-Related Disorders |
C00002057
|
D003093 | Colitis, Ulcerative |
C00002057
|
D003110 | Colonic Neoplasms |
C00002057
|
D019955 | Conduct Disorder |
C00002057
|
D003251 | Constriction, Pathologic |
C00002057
|
D003329 | Coronary Vasospasm |
C00002057
|
D003490 | Cyanosis |
C00002057
|
D003866 | Depressive Disorder |
C00002057
|
D003865 | Depressive Disorder, Major |
C00002057
|
D003872 | Dermatitis |
C00002057
|
D003924 | Diabetes Mellitus, Type 2 |
C00002057
|
D003928 | Diabetic Nephropathies |
C00002057
|
D003967 | Diarrhea |
C00002057
|
D004421 | Dystonia |
C00002057
|
D020821 | Dystonic Disorders |
C00002057
|
D001068 | Eating Disorders |
C00002057
|
D004802 | Eosinophilia |
C00002057
|
D007172 | Erectile Dysfunction |
C00002057
|
D005317 | Fetal Growth Retardation |
C00002057
|
D005334 | Fever |
C00002057
|
D005921 | Glomerulonephritis |
C00002057
|
D044882 | Glucose Metabolism Disorders |
C00002057
|
D006261 | Headache |
C00002057
|
D006258 | Head and Neck Neoplasms |
C00002057
|
D006323 | Heart Arrest |
C00002057
|
D006606 | Hiccup |
C00002057
|
D006940 | Hyperemia |
C00002057
|
D006976 | Hypertension, Pulmonary |
C00002057
|
D006984 | Hypertrophy |
C00002057
|
D006985 | Hyperventilation |
C00002057
|
D007035 | Hypothermia |
C00002057
|
D007246 | Infertility |
C00002057
|
D055959 | Intervertebral Disc Degeneration |
C00002057
|
D002542 | Intracranial Embolism and Thrombosis |
C00002057
|
D007511 | Ischemia |
C00002057
|
D007805 | Language Development Disorders |
C00002057
|
D007859 | Learning Disorders |
C00002057
|
D008107 | Liver Diseases |
C00002057
|
D008133 | Long QT Syndrome |
C00002057
|
D008171 | Lung Diseases |
C00002057
|
D008175 | Lung Neoplasms |
C00002057
|
D008569 | Memory Disorders |
C00002057
|
D028361 | Mitochondrial Diseases |
C00002057
|
D009041 | Motion Sickness |
C00002057
|
D009069 | Movement Disorders |
C00002057
|
D020267 | MPTP Poisoning |
C00002057
|
D009133 | Muscular Atrophy |
C00002057
|
D009207 | Myoclonus |
C00002057
|
D009361 | Neoplasm Invasiveness |
C00002057
|
D009362 | Neoplasm Metastasis |
C00002057
|
D009374 | Neoplasms, Experimental |
C00002057
|
D009389 | Neovascularization, Pathologic |
C00002057
|
D009410 | Nerve Degeneration |
C00002057
|
D009422 | Nervous System Diseases |
C00002057
|
D009436 | Neural Tube Defects |
C00002057
|
D019954 | Neurobehavioral Manifestations |
C00002057
|
D019636 | Neurodegenerative Diseases |
C00002057
|
D054081 | Neuronal Migration Disorders |
C00002057
|
D020258 | Neurotoxicity Syndromes |
C00002057
|
D009669 | Nose Neoplasms |
C00002057
|
D009759 | Nystagmus, Pathologic |
C00002057
|
D009765 | Obesity |
C00002057
|
D009845 | Oligospermia |
C00002057
|
D010182 | Pancreatic Diseases |
C00002057
|
D010190 | Pancreatic Neoplasms |
C00002057
|
D016584 | Panic Disorder |
C00002057
|
D030361 | Papillomavirus Infections |
C00002057
|
D010243 | Paralysis |
C00002057
|
D010291 | Paresis |
C00002057
|
D010302 | Parkinson Disease, Secondary |
C00002057
|
D010510 | Periodontal Diseases |
C00002057
|
D016491 | Peripheral Vascular Diseases |
C00002057
|
D020326 | Migraine without Aura |
C00001497
|
D011086 | Polycythemia |
C00002057
|
D011183 | Postoperative Complications |
C00002057
|
D011297 | Prenatal Exposure Delayed Effects |
C00002057
|
D003668 | Pressure Ulcer |
C00002057
|
D011605 | Psychoses, Substance-Induced |
C00002057
|
D011618 | Psychotic Disorders |
C00002057
|
D011654 | Pulmonary Edema |
C00002057
|
D011693 | Purpura |
C00002057
|
D012021 | Reflex, Abnormal |
C00002057
|
D051436 | Renal Insufficiency, Chronic |
C00002057
|
D050171 | Dyslipidemias |
C00000208
|
D012120 | Respiration Disorders |
C00002057
|
D012131 | Respiratory Insufficiency |
C00002057
|
D015619 | Respiratory System Abnormalities |
C00002057
|
D012798 | Sialorrhea |
C00002057
|
D012848 | Sinoatrial Block |
C00002057
|
D012878 | Skin Neoplasms |
C00002057
|
D012893 | Sleep Disorders |
C00002057
|
D007319 | Sleep Initiation and Maintenance Disorders |
C00002057
|
D055752 | Small Cell Lung Carcinoma |
C00002057
|
D013035 | Spasm |
C00002057
|
D016137 | Spina Bifida Cystica |
C00002057
|
D013117 | Spinal Cord Compression |
C00002057
|
D019956 | Stereotypic Movement Disorder |
C00002057
|
D013274 | Stomach Neoplasms |
C00002057
|
D013276 | Stomach Ulcer |
C00002057
|
D013345 | Subarachnoid Hemorrhage |
C00002057
|
D019966 | Substance-Related Disorders |
C00002057
|
D013398 | Sudden Infant Death |
C00002057
|
D013610 | Tachycardia |
C00002057
|
D013919 | Thromboangiitis Obliterans |
C00002057
|
D013927 | Thrombosis |
C00002057
|
D020323 | Tics |
C00002057
|
188890 | TOBACCO ADDICTION, SUSCEPTIBILITY TO |
C00002057
|
D014029 | Tobacco Use Disorder |
C00002057
|
D005879 | Tourette Syndrome |
C00002057
|
D014133 | Tracheal Diseases |
C00002057
|
D001745 | Urinary Bladder Diseases |
C00002057
|
D014652 | Vascular Diseases |
C00002057
|
D014657 | Vasculitis |
C00002057
|
D018366 | Vasculitis, Leukocytoclastic, Cutaneous |
C00002057
|
D018879 | Ventricular Premature Complexes |
C00002057
|
D015430 | Weight Gain |
C00002057
|
D001249 | Asthma |
C00001497
|
D011230 | Precancerous Conditions |
C00001428
|